Substituted bicyclic compounds for treating multidrug resistance
申请人:——
公开号:US20020082262A1
公开(公告)日:2002-06-27
Substituted bicyclic compounds for treating multidrug resistance are disclosed. Compositions and methods of use for the substituted bicyclic compounds are disclosed. Suitable substituted bicyclic compounds include:
1
Substituted heterocyclic compounds for treating multidrug resistance
申请人:The Procter Gamble Co.
公开号:US20020099215A1
公开(公告)日:2002-07-25
Substituted heterocyclic compounds are disclosed. The compounds are useful for treating multidrug resistance. The compounds can be formulated in compositions with a carrier and, optionally, a therapeutic agent. One suitable substituted heterocyclic compound has the formula:
1
Compounds having heterocyclic groups containing two nitrogen atoms for treating multidrug resistance
申请人:——
公开号:US20020115659A1
公开(公告)日:2002-08-22
Compounds having heterocyclic groups containing two nitrogen atoms are disclosed. The compounds are useful for treating multidrug resistance. The compounds can be formulated in compositions with a carrier and, optionally, a therapeutic agent. One suitable compound has the formula:
1
SUBSTITUTED HETEROCYCLIC COMPOUNDS FOR TREATING MULTIDRUG RESISTANCE
申请人:Degenhardt Raymond Charles
公开号:US20060223853A1
公开(公告)日:2006-10-05
Compounds suitable for treating multidrug resistance and methods for their preparation and use are disclosed. The compounds are represented by the following formula:
or an optical isomer, diastereomer, enantiomer or pharmaceutically acceptable salt thereof.
Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
申请人:The Procter & Gamble Co.
公开号:US06376514B1
公开(公告)日:2002-04-23
Substituted heterocyclic compounds are disclosed. The compounds are useful for treating multidrug resistance. The compounds can be formulated in compositions with a carrier and, optionally, a therapeutic agent. One suitable substituted heterocyclic compound has the formula: